The global vaccine adjuvants market was valued at USD 1,175 百万 2021 兑美元 2,176 百万 2028, 复合年增长率为 9.2% 从 2022 到 2028, according to Gen Consulting Company.

该行业报告提供了全球市场的市场预测, 接下来是对产品的详细分析, disease, 应用, 和地区. The global market data on vaccine adjuvants can be segmented by product: adjuvant emulsions, bacteria-derived adjuvants, carbohydrate adjuvants, liposome adjuvants, mineral salt-based adjuvant, tensoactive adjuvants, virus-like particles (VLP), 其他的. The mineral salt-based adjuvant segment held the largest share of the global vaccine adjuvants market in 2021 预计在预测期内将持有其份额. Vaccine adjuvants market is further segmented by disease: cancer, infectious diseases, 其他的. 全球范围, the infectious diseases segment made up the largest share of the vaccine adjuvants market. Based on application, the vaccine adjuvants market is segmented into: 商业的, research. 根据地区, the vaccine adjuvants market also can be divided into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

The global vaccine adjuvants market is highly competitive. Key companies profiled in the report include Agenus Inc., Associated British Foods plc (SPI Pharma Inc.), Avanti Polar Lipids Inc., Croda International plc (Brenntag Biosector A/S), CSL Limited, Dynavax Technologies Corporation, GSK plc, InvivoGen Corp., Merck & 钴. 公司, MVP Laboratories Inc. (Phibro Animal Health Corporation), Novavax Inc., OZ Biosciences SAS, Seppic SA (Air Liquide S.A.).

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
– Get a detailed picture of the Global Vaccine Adjuvants Market
– Identify segments/areas to invest in over the forecast period in the Global Vaccine Adjuvants Market
– 了解竞争环境, 市场的领先参与者
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.